Frontlight ResearchEarly access
Colorectal cancer trials in China
616 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peoplePrediction Model of Colorectal Adenoma Recurrence-Carcinogenesis Risk With TCM-WM Multimodal Feature Fusion
- Where
- Beijing
- Age
- 18 years and over
- People
- 3,000
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT07611266 - Phase 1/2Taking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Daping, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Nanjing, Shanghai, Shatin, Shenyang, Shenzhen, Taiyuan, Weifang, Wuhan, Xiamen, Xi'an, Xuzhou, Zhengzhou
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseTaking peopleElectrolyte Beverage Combined With Polyethylene Glycol for Colonoscopy Bowel Preparation
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 405
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07608120 - Early phase 1Taking peopleCDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
- Where
- Hangzhou
- Age
- 18 years to 70 years
- People
- 36
- Run by
- Zhejiang University
See details and how to joinNCT06937567 - Phase 2Taking peopleClinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 236
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07176182 - No phaseTaking peopleSomatostatin Plus Clear Liquid Diet Versus Diverting Stoma in Patients With Rectal Cancer Undergoing Ultra-Low Anterior Resection
- Where
- Ezhou, Wuhan
- Age
- 18 years to 75 years
- People
- 72
- Run by
- Tongji Hospital
See details and how to joinNCT07605611 - Phase 1/2Taking peopleA Study of JMT203 in Patients With Cancer Cachexia
- Where
- Zhejiang
- Age
- 18 years and over
- People
- 307
- Run by
- Shanghai JMT-Bio Inc.
See details and how to joinNCT06868849 - Phase 2Taking peopleToripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 105
- Run by
- Sun Yat-sen University
See details and how to joinNCT06903858 - Phase 2/3Taking peopleA Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer
- Where
- Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Hangzhou, Kunming, Meizhou, Nanjing, Shanghai, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Wuxi, Zhengzhou
- Age
- 18 years to 75 years
- People
- 80
- Run by
- RemeGen Co., Ltd.
See details and how to joinNCT07462143 - No phaseTaking peopleChina Metastatic Liver Cancer Clinical Registry Cohort Database
- Where
- Bengbu, Hefei, Qingdao
- Age
- 18 years to 80 years
- People
- 2,000
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT07602504 - Phase 2Taking peopleA Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy
- Where
- Shanghai
- Age
- 18 years and over
- People
- 40
- Run by
- Fudan University
See details and how to joinNCT07604909 - Phase 2Taking peopleShort-Course Radiotherapy Followed by Immunotherapy Combined With Chemotherapy for Microsatellite Stable Locally Advanced Rectal Cancer: A Prospective, Randomized, Controlled Phase II Clinical Trial
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 130
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07594925 - Phase 1Not yet taking people in ChinaA Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 18
- Run by
- Beijing DCTY Biotech Co.,Ltd.
See details and how to joinNCT07014878 - Phase 2Taking peopleImmune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers
- Where
- Beijing
- Age
- 18 years and over
- People
- 34
- Run by
- Peking University
See details and how to joinNCT06580574 - Phase 1/2Taking peopleDual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer
- Where
- Shenzhen
- Age
- 18 years to 75 years
- People
- 48
- Run by
- Beijing Biotech
See details and how to joinNCT07589517 - Early phase 1Not yet taking people in ChinaA Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 20
- Run by
- SmartNuclide Biopharma
See details and how to joinNCT07590856 - No phaseTaking people18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- Where
- Beijing
- Age
- 18 years and over
- People
- 200
- Run by
- Peking University First Hospital
See details and how to joinNCT07557225 - Phase 2Taking peopleRomiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors
- Where
- Beijing
- Age
- 18 years and over
- People
- 220
- Run by
- Peking University People's Hospital
See details and how to joinNCT07586813 - Phase 3Taking peopleA Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 444
- Run by
- Tao Zhang
See details and how to joinNCT07113275 - Phase 1/2Taking peopleNeoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 138
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07365592 - Phase 2/3Not yet taking people in ChinaA Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal Cancer
- Where
- Shijiazhuang
- Age
- 18 years to 75 years
- People
- 408
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT07585279 - Phase 2Not yet taking people in ChinaA Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 70
- Run by
- Jiangsu Cancer Institute & Hospital
See details and how to joinNCT07446387 - No phaseTaking peopleSuperior HypogastrIc plExus bLock During Laparoscopic Colorectal Cancer Surgery
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 170
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07579780 - Phase 2Taking peopleNeoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable Metastases
- Where
- Hangzhou
- Age
- 18 years to 85 years
- People
- 40
- Run by
- Zhejiang University
See details and how to joinNCT07581912 - Phase 2Enrolling by invitationThe Efficacy and Safety of IBI351, Cetuximab β Combined With FOLFIRI as First-line /IBI351, Cetuximab β as Second-line in the Treatment of KRAS G12C-mutated Metastatic Colorectal Cancer
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 50
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06959589